If I had an extra 100K, I would buy CYDY immediately based on what he SAID and DID!
CA: I’ve seen a lot of molecules over the last 15 years. I’ve also seen a lot of different clinical programs in which the same molecule is being used in different programs. To me, leronlimab has all the hallmarks of a winner.
I continually tell the team that we are really fortunate. It’s a gift that we have this molecule in our hands and that we can develop it, because we have something that we really believe works. The molecule is fantastic. There is a path here to value generation and to helping patients with this molecule. The future is exciting. We look forward to coming together with a strategic partner that can help CytoDyn get this molecule over the finish line.